Related Experiment Video

Updated: May 10, 2026

Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus
09:03

Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus

Published on: September 5, 2013

Impact of target site distribution for Type I restriction enzymes on the evolution of methicillin-resistant

Gareth A Roberts1, Patrick J Houston, John H White

  • 1EaStCHEM School of Chemistry, University of Edinburgh, The King's Buildings, Edinburgh EH9 3JJ, UK and Division of Clinical Sciences, St. George's, University of London, Cranmer Terrace, London, SW17 0RE, UK.

Nucleic Acids Research
|June 18, 2013
PubMed

Insights

Dominant Methicillin-resistant Staphylococcus aureus (MRSA) lineages possess unique Type I restriction-modification (RM) systems that block gene transfer, driving independent evolution. However, specific plasmids evade these systems, promoting antibiotic resistance spread.

Area of Science:

  • Microbiology
  • Bacterial genetics
  • Evolutionary biology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a major global pathogen responsible for numerous infections.
  • Distinct MRSA lineages are associated with unique Type I restriction-modification (RM) systems, influencing their genetic behavior.
  • Understanding these RM systems is crucial for deciphering MRSA evolution and antibiotic resistance dissemination.

Purpose of the Study:

  • To identify the specific DNA sequence targets of Type I RM systems in dominant MRSA lineages (CC1, CC5, CC8, ST239).
  • To experimentally validate the role of these RM systems in restricting horizontal gene transfer (HGT) between MRSA strains.
  • To investigate the distribution of RM target sites within MRSA genomes and plasmids and its impact on evolution.

Main Methods:

  • Bioinformatic analysis to identify RM target sites in dominant MRSA lineages.
  • Experimental validation of RM system function in blocking HGT.
  • Genomic and plasmid analysis to determine target site distribution patterns.

Main Results:

  • Specific DNA targets for Type I RM systems in MRSA lineages CC1, CC5, CC8, and ST239 were identified.
  • The Type I RM system was confirmed to be sufficient to prevent HGT between MRSA lineages, supporting independent evolution.
  • RM target sites were randomly distributed in S. aureus genomes but absent in key conjugative plasmids encoding resistance genes.
  • Absence of target sites in plasmids facilitates their evasion of RM systems, promoting inter-lineage spread.

Conclusions:

  • RM systems act as a significant barrier to HGT in MRSA, contributing to lineage-specific evolution.
  • The evasion of RM systems by specific plasmids is a key factor in the spread of antibiotic resistance among MRSA strains.
  • This research elucidates evolutionary patterns in MRSA, highlighting the role of RM systems and plasmid adaptability in the emergence of resistant strains.

More Related Videos

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance09:00

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance

Published on: May 2, 2018

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Mismatch Repair01:36

Mismatch Repair

Overview
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...